welcome
CNBC

CNBC

Health

Health

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

CNBC
Summary
Nutrition label

83% Informative

Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price.

The company is offering those vials through its direct-to-consumer website, LillyDirect , which started offering lower doses of the drug in vials in August .

Patients diagnosed with obesity alone or with obstructive sleep apnea can pay for the vials themselves on the site.

Around 10% of new patients in the obesity market who start a treatment are using Zepbound through LillyDirect 's self-pay pharmacy.

LillyDirect connects people with an independent telehealth company that can prescribe certain drugs if the patients are eligible.

The site also offers a home-delivery option if the prescribed treatment is Eli Lilly's .

VR Score

80

Informative language

78

Neutral language

62

Article tone

formal

Language

English

Language complexity

55

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links